The healthcare AI space will be an exciting one to watch over the next couple years, as investment dollars flow to startups and providers launch more AI pilots. Two of the most interesting trends to watch will be the use cases that healthcare organizations prioritize when deploying generative AI models, as well as M&A activity within the healthcare AI field, a CB Insights analyst declared during a recent webinar.
Peter Long, Executive Vice President, Strategy and Health Solutions, at Blue Shield of California joins us on the Payer's Place to discuss how they are making the patient experience better for their members. He also shares how Virtual Blue, a virtual-first PPO will help remove barriers to care, so employees can get care when and how they want it.
Connect and network with the best in the healthcare industry in Dallas on October 26th all day and during our exclusive networking reception that evening. Don't miss your opportunity to find new partners, talk to VCs, elbow with C-Suite and so much more. Hurry and save $150, but only until 8/25.
CMS' Enhancing Oncology Model and Cancer Moonshot are the forcing functions to achieve value-based care in oncology. In the spirit of working together to improve lives, this is a MUST for physicians to consider–before they get left behind.
An AI-driven app called juli improved symptoms of asthma and depression, two randomized controlled trials found. The app takes in data from electronic medical records, smartphones, wearable devices, the environment and patient questionnaires to provide personalized health recommendations.
While greater operational efficiency and cost control are essential to the success of VBC initiatives, so too is patient engagement. Care coordination and care management are far more difficult – and far less likely to achieve optimal outcomes – without patients who are fully engaged with their providers.
Ceribell Inc., based in Sunnyvale, California, has developed a point-of-care EEG system that provides real-time seizure monitoring and alerting, which helps in the rapid and precise treatment of patients with suspected non-convulsive seizures. The FDA-cleared Ceribell ClarityPro software uses a machine-learning model to analyze EEG signals and generate bedside alerts.
No comments